£22.51
Add to Cart
Vigalex Forte 2000 IU 120 tablets
8 available, 2 sold
Details
Shipping: United Kingdom: £1044.00 (more destinations)
Condition: Brand new
Returns: does not accept (more)
Vigalex Forte 2000 IU 120 tablets
Vigalex Forte (2000 IU): One tablet contains 20 mg of cholecalciferol, powder, equivalent to 0.05 mg (2000 IU) of cholecalciferol (vitamin D( 3 ). Indications for use: Prevention of rickets and osteomalacia in children and adults, prevention of vitamin deficiency D in women planning a pregnancy, during pregnancy and breastfeeding in consultation with a doctor, prevention of vitamin D deficiency in children and adults, supportive treatment of osteoporosis in adults. Contraindications :
hypersensitivity to the active substance (cholecalciferol) or to any of the excipients, hypercalcemia and/or hypercalciuria, nephrolithiasis and/or severe renal failure, pseudohypoparathyroidism (the need for vitamin D may be reduced due to periods of normal sensitivity to this vitamin, leading to overdose). In this case, more manageable vitamin D derivatives are available. Responsible entity: Biofarm Sp. z o. o., ul. Wałbrzyska 13, 60-198 Poznań.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
DISCLAMER!!!! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Vigalex Forte (2000 IU): One tablet contains 20 mg of cholecalciferol, powder, equivalent to 0.05 mg (2000 IU) of cholecalciferol (vitamin D( 3 ). Indications for use: Prevention of rickets and osteomalacia in children and adults, prevention of vitamin deficiency D in women planning a pregnancy, during pregnancy and breastfeeding in consultation with a doctor, prevention of vitamin D deficiency in children and adults, supportive treatment of osteoporosis in adults. Contraindications :
hypersensitivity to the active substance (cholecalciferol) or to any of the excipients, hypercalcemia and/or hypercalciuria, nephrolithiasis and/or severe renal failure, pseudohypoparathyroidism (the need for vitamin D may be reduced due to periods of normal sensitivity to this vitamin, leading to overdose). In this case, more manageable vitamin D derivatives are available. Responsible entity: Biofarm Sp. z o. o., ul. Wałbrzyska 13, 60-198 Poznań.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
DISCLAMER!!!! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LT, Panevezys
